Antitumor and antimetastatic activities of plasmid pcDNA3.1-IPl0 complexed with cationic liposome in mice with 4T1 breast cancer

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 2, 2009, Pages 195-198

  Tang, Qing Qing ^a   Shi, Wei ^a   Lü, Hui Min ^a   Peng, Xing Chen ^a   Wen, Yan Jun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Breast cancer; Cationic liposome; Gene therapy; IP10

Indexed keywords

CATION; COMPLEMENTARY DNA; CXCL10 PROTEIN, MOUSE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIPOSOME;

ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENE THERAPY; GENETICS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; MOUSE; PATHOLOGY; PLASMID; RANDOMIZATION; SECONDARY;

ANIMALS; CATIONS; CHEMOKINE CXCL10; DNA, COMPLEMENTARY; FEMALE; GENETIC THERAPY; LIPOSOMES; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PLASMIDS; RANDOM ALLOCATION;

EID: 63449094323     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Guo J, Wang B, Zhang M, et al. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther,2002;9(12):793-803.
2. Angiolillo AL, Sgadari C, Taub DD, et al. Human interferon- inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med,1995;182 (1):155-162.
3. Phillips AJ. The challenge of gene therapy and DNA delivery. J Pharm Pharmacol,2001;53(9):1169-1174.
4. Pulaski BA, Terman DS, Khan S, et al. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res,2000;60(10):2710-2715.
5. Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res, 1998;58(7):1486-1493.
6. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol, 1994;6(6):865-873.
7. Kim CH, Broxmeyer HE. Chemokines, signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol,1999;65(1):6-15.
8. Keyser J, Schultz J, Ladell K, et al. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency. Exp Dermatol,2004;13(6):380-390.
9. Templeton NS, Lasic DD, Frederik PM, et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol,1997;15(7):647-652.
10. Ito I, Began G, Mohiuddin I, et al. Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration. Mol Ther,2003;7(3):409-418.
11. Whitmore M, Li S, Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther,1999;6(11):1867-1875.